Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) - Saraceni, Francesco; Labopin, Myriam; Brecht, Arne; Kröger, Nicolaus; Eder, Matthias; Tischer, Johanna; Labussière-Wallet, Hélène; Einsele, Hermann; Beelen, Dietrich; Bunjes, Donald; Niederwieser, Dietger; Bochtler, Tilmann; et al. (BioMed Central, 2019)
In: Journal of Hematology & Oncology, 12 (2019), Nr. 44. pp. 1-10. ISSN 1756-8722